--An expert panel under India's drug regulator recommended emergency use authorization for Novavax Inc.'s Covovax vaccine produced by the Serum Institute of India and Indian pharmaceutical company Biological E's Corbevax vaccine, India's Economic Times reports.

--The subject expert committee also gave the nod to Merck & Co.'s Covid-19 pill molnupiravir, according to the report.

--The recommendations have been sent to the Drugs Controller General of India for approval, the Economic Times reports, citing unnamed sources.

Full story: https://bit.ly/3evZir6

Write to Singapore Editors at singaporeeditors@dowjones.com

(END) Dow Jones Newswires

December 28, 2021 00:52 ET (05:52 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Merck Charts.
Merck (NYSE:MRK)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Merck Charts.